Navigation Links
Thomson Reuters to Host tranSMART Community Meeting During BIO-IT World Conference
Date:4/4/2013

PHILADELPHIA, April 4, 2013 /PRNewswire/ -- The IP & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced it will host—in collaboration with the Pistoia Alliance and the tranSMART Foundation—a tranSMART Community meeting April 10, 6:30 to 8:30 p.m., at the Thomson Reuters office at 22 Thomson Place, Boston.

This meeting will bring together key stakeholders from universities, non-profit research organizations, pharmaceutical and biotechnology companies, and vendors to discuss the future of translational research and to help speed promising discoveries from the laboratory to the clinic. It will also provide attendees with an overview of the tranSMART open-source, community-driven platform.

Presentations include an overview of the tranSMART Foundation (community home); a roadmap outlining tranSMART as the preferred data sharing and analytics platform for translational biomedical research; major initiatives and active projects including eTRIKS and TraIT; and the development of a partner network offering content and data curation, platform provisioning and implementation services. 

This meeting is open to all interested parties but space is limited. Reservations for a space can be made online.  Attendees will be welcomed on a first come, first served basis.

"The tranSMART community meeting in Boston is a great opportunity for interested parties to come together to learn the latest about our activity to date," said Dr. Brian Athey , co-chief executive officer of the tranSMART Foundation and chair of the Department of Computational Medicine and Bioinformatics at the University of Michigan Medical. "We continue to make steady progress in our efforts and are encouraged by the opportunity to highlight recent developments and future plans for tranSMART and to continue to grow our open source community. Many thanks to Thomson Reuters for supporting our international efforts."

Dr. Michael Braxenthaler , co-chief executive officer of the tranSMART Foundation and Chairman of the Pistoia Alliance, added, "We are very happy to have Thomson Reuters involved in tranSMART and are looking forward to hosting the meeting with them and generating more interest in the community."

"Our staff has been involved in providing implementation, development and deep curation expertise for relevant biological data for tranSMART since the inception of its platform," said Joe Donahue , senior vice president at Thomson Reuters. "We are pleased to continue to support tranSMART, together with the tranSMART Foundation and the Pistoia Alliance, and the organizations that wish to implement it."

For more information about the tranSMART professional solutions available from Thomson Reuters, please visit: http://thomsonreuters.com/content/science/pdf/ls/LS-201210-SCI-TRS-TranSMART-Brochure.pdf.

tranSMART Foundation
The tranSMART FOUNDATION is a global non-profit organization devoted to realizing the promise of translational biomedical research through development of the tranSMART knowledge management platform. The mission of the tranSMART Foundation is to enable effective sharing, integration, standardization and analysis of heterogeneous data from collaborative translational research by mobilizing the tranSMART open-source and open-data community.  The Pistoia Alliance and the University of Michigan are Co-founding members of the tranSMART Foundation.

For more information, go to www.transmartfoundation.org/.

Pistoia Alliance
Since 2009, the Pistoia Alliance (www.pistoiaalliance.org) has worked to lower barriers to innovation by improving the interoperability of R&D business processes. Alliance members include over 70 life science companies, vendors, and content providers.

Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minn., Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Online Resource Offers Key Trends in Scientific Research and Performance Analysis
2. Thomson Reuters Partners with CHDI Foundation to Develop Systems Biology Tools for Huntingtons Disease
3. Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services
4. Thomson Reuters Research Forecasts the Onset of the Targeted Drug Discovery Era
5. Professor of Art from Northern Virginia Community College Lectures at Cajal Institute
6. Rosemary Gladstar Receives First-Annual ABC Mark Blumenthal Herbal Community Builder Award
7. TopCoders Open Community Challenge Process Yields 970 Fold Increase in Speed for Big Data Genomics Sequencing Algorithm
8. SPIE Leaders Urge Photonics Community to Assert Need for Full Horizon 2020 Funding
9. BioSpace Spotlights Northwests Life Science Community
10. BioSpace Spotlights Thriving Bay Area Life Science Community
11. BioSpace Spotlights the growing Midwest Life Science Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017   Sienna Biopharmaceuticals, Inc. , a privately ... that Richard Peterson will join the company ... Peterson, who brings more than two decades of global ... is retiring at the end of April but will ... joins Sienna from Novan, Inc., where he served as ...
(Date:3/23/2017)... BETHESDA, Md. , March 23, 2017 /PRNewswire/ ... company developing DCVax® personalized immune therapies for solid ... on the $7.5 million financing it announced last ... Company sold to several institutional investors securities totaling ... $.26 per share, and 10,000,000 shares of Class ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced ... the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business ... joint development activities. , “Dr. Floyd’s career has spanned 30 years in the ...
Breaking Biology Technology:
(Date:3/2/2017)... LONDON , March 2, 2017 Summary ... require to better understand Merck KGaA and its partnering ... report: https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals ... into the partnering activity of one of the world,s ... reports are prepared upon purchase to ensure inclusion of ...
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):